✦ LIBER ✦

Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients

✍ Scribed by Herschel S. Zackheim; Smita Amin; Mohammed Kashani-Sabet; Alex McMillan

Book ID: 117397043
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 131 KB
Volume: 40
Category: Article
ISSN: 1097-6787
DOI: 10.1016/s0190-9622(99)70491-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extracorporeal photochemotherapy in long

Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma

✍ P. Rubegni; G. De aloe; M. Fimiani 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Long-term implications of T-cell recepto

Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma

✍ Joan Guitart; Charles Camisa; Michelle Ehrlich; Wilma F. Bergfeld 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Evaluation of the Long-Term Tolerability

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

✍ Duvic, Madeleine; Olsen, Elise A.; Breneman, Debra; Pacheco, Theresa R.; Parker, 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 201 KB

Molecular identity of skin and blood T-c

Molecular identity of skin and blood T-cell clones in cutaneous T-cell lymphoma patients as determined from the migration pattern of the T-cell receptor-γ gene by capillary electrophoresis

✍ Brigitte Gubler; Sophie Marty-Grès; Bernard Guillot; Jean-François Eliaou; Olivi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

2159 Total skin electron beam therapy(TS

2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL)

✍ Peter A. Quiros; Barry M. Kacinski; Peter Heald; Richard Edelson; Irwin Braverma 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 136 KB

High-dose therapy and autologous stem ce

High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma

✍ Zamkoff, K W; Matulis, M D; Mehta, A C; Beaty, M W; Hutchison, R E; Gentile, T C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB